Does PACLITAXEL Cause Bladder transitional cell carcinoma? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Bladder transitional cell carcinoma have been filed in association with PACLITAXEL (PACLITAXEL PACLITAXEL). This represents 0.0% of all adverse event reports for PACLITAXEL.
5
Reports of Bladder transitional cell carcinoma with PACLITAXEL
0.0%
of all PACLITAXEL reports
3
Deaths
1
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From PACLITAXEL?
Of the 5 reports, 3 (60.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PACLITAXEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PACLITAXEL Cause?
Neutropenia (4,553)
Nausea (4,521)
Dyspnoea (4,519)
Diarrhoea (4,289)
Off label use (4,075)
Anaemia (3,949)
Neuropathy peripheral (3,508)
Malignant neoplasm progression (3,484)
Fatigue (3,418)
Death (3,143)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which PACLITAXEL Alternatives Have Lower Bladder transitional cell carcinoma Risk?
PACLITAXEL vs PACRITINIB
PACLITAXEL vs PALBOCICLIB
PACLITAXEL vs PALIPERIDONE
PACLITAXEL vs PALIVIZUMAB
PACLITAXEL vs PALONOSETRON